phrykt

iSpecimen Inc. (ISPC): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of ISPC were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

No ISPC insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ISPC short interest

High short interest. 12.1% of ISPC shares are sold short: about 1 share in 8. Over the last 12 reports the number of shares short went up 170%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 305,211 ISPC shares were sold short, 12.1% of the shares outstanding, up 92.3% from the report before. At the average daily volume of 412,744 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

12.1%May 15Oct 3013.9%

Days to cover

1.0May 15Oct 304.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026305,21112.12%+92%412,7441.0
Oct 15, 2026158,7546.30%-1%79,5002.0
Sep 30, 2026160,9926.39%-27%594,7511.0
Sep 15, 2026220,7228.76%+53%2.21M1.0
Aug 31, 2026143,9805.72%-4%929,5421.0
Aug 14, 2026149,7055.94%-18%77,5501.9
Jul 31, 2026181,5330.61%-2%47,1943.9
Jul 15, 2026184,5050.62%+18%153,3701.2
Jun 30, 2026156,6500.53%-14%68,2392.3
Jun 15, 2026182,7620.62%-24%109,4171.7
May 29, 2026241,0560.81%+114%386,1181.0
May 15, 2026112,8400.38%+119%1.08M1.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

iSpecimen company events

iSpecimen filed 28 reports on Form 8-K in the last 12 months, 7 of them about an important change (leadership, control, listing). The latest was on Nov 9, 2026.

  1. Nov 9, 2026AgreementISpecimen Inc. entered into a securities purchase agreement with certain accredited investors for the issuance and sale, in a private placement, of 500 shares of the Company’s Series D Convertible Preferred Stock, par value $0.0001 per share, at a purchase price of $800 per share, and a $1,000… Filing
  2. Nov 5, 2026ControlThe information set forth in Items 1.01, 2.01 and 3.02 of this Current Report on Form 8-K is incorporated herein by reference. Filing
  3. Nov 2, 2026VoteReported shareholder vote results. Filing
  4. Oct 9, 2026VoteReported shareholder vote results. Filing
  5. Sep 10, 2026ListingISpecimen Inc. received a letter dated September 8, 2026 from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that it had been granted an extension of time to regain compliance with Nasdaq Listing Rule 5550(b). Filing
  6. Sep 4, 2026AgreementISpecimen Inc., a Delaware corporation, entered into an Asset Purchase Agreement with Foldlab AI Ltd., a company organized under the laws of British Columbia, pursuant to which the Company will acquire from Foldlab certain artificial intelligence software, models, source code, data rights… Filing
  7. Aug 31, 2026LeadershipDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers. Filing
  8. Aug 14, 2026AgreementISpecimen Inc. entered into a Consulting Agreement with IR Agency LLC, pursuant to which the Consultant agreed to provide marketing and advertising services designed to communicate information about the Company to the financial community, including the creation of company profiles and media… Filing
  9. Aug 11, 2026AgreementISpecimen Inc. entered into a Settlement Agreement and Mutual Release with WestPark Capital, Inc. to resolve all disputes between them, including the arbitration captioned WestPark Capital, Inc. v. iSpecimen, Inc., JAMS Ref. Filing
  10. Aug 7, 2026AgreementISpecimen Inc. entered into a placement agency agreement with E.F. Hutton & Co., and a securities purchase agreement with investors in connection with which the Company agreed to issue and sell, in a “reasonable best efforts” public offering (i) 996,231 shares of the Company’s common stock, par… Filing
  11. Jul 14, 2026AnnouncementISpecimen Inc. completed Milestone 3 in the Company’s digital transformation program powered by SalesStack Solutions. Filing
  12. Jun 1, 2026ListingISpecimen Inc. received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that it no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5 million in stockholders’ equity for continued listing on the Nasdaq… Filing
  13. May 29, 2026VoteReported shareholder vote results. Filing
  14. May 13, 2026ListingAs previously disclosed on a Current Report on Form 8-K filed with the Securities and Exchange Commission on November 21, 2025, on November 19, 2025, the Company received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that the… Filing
  15. May 1, 2026AnnouncementThe Company issued a press release announcing the Reverse Stock Split. Filing
  16. Apr 13, 2026AnnouncementISpecimen Inc. convened its 2025 Annual Meeting of Stockholders. Filing
  17. Apr 10, 2026AnnouncementShared information with investors. Filing
  18. Mar 13, 2026AnnouncementISpecimen Inc. convened its 2025 Annual Meeting of Stockholders. Filing
  19. Feb 23, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Filing
  20. Feb 18, 2026AnnouncementISpecimen Inc. convened its 2025 Annual Meeting of Stockholders. Filing
  21. Feb 6, 2026AnnouncementShared information with investors. Filing
  22. Jan 27, 2026AnnouncementISpecimen Inc. convened its 2025 Annual Meeting of Stockholders. Filing
  23. Jan 16, 2026RulesAmended an earlier report. Changed its bylaws or articles. Filing
  24. Jan 5, 2026AnnouncementISpecimen Inc. convened its 2025 Annual Meeting of Stockholders. Filing
  25. Jan 5, 2026AgreementAs previously disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 2, 2026, iSpecimen Inc., a Delaware corporation (Nasdaq: ISPC), completed a private placement, on December 31, 2025, of its Series C Convertible Non-Voting Preferred Stock. Filing
  26. Jan 2, 2026AgreementISpecimen Inc., a Delaware corporation (Nasdaq: ISPC), entered into a Securities Purchase Agreement with certain accredited investors, pursuant to which the Company agreed to sell, and the Investors agreed to purchase, 6,875 shares of the Company’s newly-designated Series C Convertible Non-Voting… Filing
  27. Dec 1, 2025AnnouncementISpecimen Inc. received a letter from the Nasdaq Listing Qualifications Staff notifying the Company that the Staff has determined the Company now complies with the continued listing requirements under Nasdaq Listing Rules 5550(b)(1), 5550(b)(2), and 5550(b)(3). Filing
  28. Nov 21, 2025ListingISpecimen Inc. received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that the closing bid price of the Company’s common stock had been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

iSpecimen financials

Famous investors that hold ISPC

1 of the 50 well-known investors we track reported holding ISPC in their latest 13F filing. The largest position is Ken Griffin's, worth $43.9K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202637,165$43.9K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about iSpecimen Inc. (ISPC) stock

Are ISPC insiders buying or selling?

No ISPC insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in ISPC?

As of Oct 30, 2026, 305,211 ISPC shares were sold short, 12.1% of the shares outstanding, up 92.3% from the report before. At the average daily volume of 412,744 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Which famous investors hold ISPC?

1 of the 50 well-known investors we track reported ISPC in their latest 13F filing, including Ken Griffin. The largest position is worth $43.9K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.